Australia markets open in 18 minutes

Xtant Medical Holdings, Inc. (XTNT)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.8372+0.0528 (+6.73%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 102.14M
Enterprise value 119.99M
Trailing P/E 78.44
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.09
Price/book (mrq)1.99
Enterprise value/revenue 1.31
Enterprise value/EBITDA 23.64

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 327.87%
S&P500 52-week change 321.61%
52-week high 31.4500
52-week low 30.6000
50-day moving average 31.0460
200-day moving average 31.1021

Share statistics

Avg vol (3-month) 3153.88k
Avg vol (10-day) 3135.86k
Shares outstanding 5130.22M
Implied shares outstanding 6130.22M
Float 839.72M
% held by insiders 18.16%
% held by institutions 169.27%
Shares short (28 Mar 2024) 4280.58k
Short ratio (28 Mar 2024) 41.57
Short % of float (28 Mar 2024) 40.94%
Short % of shares outstanding (28 Mar 2024) 40.22%
Shares short (prior month 29 Feb 2024) 4172.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 314 Feb 2018
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 314 Feb 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.72%
Operating margin (ttm)-13.54%

Management effectiveness

Return on assets (ttm)-8.31%
Return on equity (ttm)1.54%

Income statement

Revenue (ttm)91.3M
Revenue per share (ttm)0.77
Quarterly revenue growth (yoy)84.10%
Gross profit (ttm)N/A
EBITDA -6.98M
Net income avi to common (ttm)660k
Diluted EPS (ttm)0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.71M
Total cash per share (mrq)0.04
Total debt (mrq)23.56M
Total debt/equity (mrq)45.88%
Current ratio (mrq)2.82
Book value per share (mrq)0.39

Cash flow statement

Operating cash flow (ttm)-9.52M
Levered free cash flow (ttm)-25.38M